Lv41
490 积分 2025-02-22 加入
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
16分钟前
已完结
Imagination and empathy in the consultation
19分钟前
已关闭
Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis
6小时前
已完结
Efficacy and Safety of Janus Kinase Inhibitors in Patients with Vitiligo: A Systematic Review and Meta‐Analysis
1个月前
已完结
JAK inhibitors for the treatment of vitiligo
1个月前
已完结
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
1个月前
已完结
Consensus on the safety and risks of laser and intense pulse light treatments in patients with vitiligo: An e-Delphi study
2个月前
已完结
Low‐Dose Baricitinib Plus Narrow‐Band Ultraviolet B for the Treatment of Progressive Non‐Segmental Vitiligo: A Prospective, Controlled, Open‐Label Study
2个月前
已完结
The possible role of Wnt/β‐catenin signalling in vitiligo treatment
2个月前
已完结
Significant improvement of vitiligo with oral tofacitinib treatment
2个月前
已完结
皖公网安备34019202002308
